294.2 𩺠åèç
294.2.1 é«é »èé»
294.2.1.1 Athletic Heart Adaptations
- Endurance: eccentric LVH + LV dilation
- Strength: concentric LVH
- Bradycardia, 1° AV block, Wenckebach
- ECG voltage LVH alone (no clinical significance)
- Detraining reverses changes
294.2.1.2 SCD in Athletes
- < 35 yo: HCM (US) / anomalous coronary (Italy) / ARVC / LQT / Brugada / WPW / myocarditis / commotio cordis / Marfan dissection
35 yo: CAD primary
294.2.1.3 Pre-Participation Screening
- Italian: mandatory ECG (â SCD ~ 90%)
- US AHA: history + physical (ECG selectively)
- ESC / IOC: ECG recommended
294.2.1.4 Athletic ECG Variants (Normal)
- Sinus bradycardia
- 1° AV block
- Wenckebach
- IRBBB or CRBBB (with normal QRS)
- Voltage LVH alone
- Early repolarization
294.2.1.5 Athletic ECG Findings to Investigate
- T-wave inversion in lateral or inferolateral leads
- Pathologic Q
- Complete LBBB
- ST depression
- Mobitz II or higher AVB
- Long QTc (> 460 men, > 470 women)
- Brugada pattern
- WPW pre-excitation
- Epsilon waves (ARVC)
294.2.1.6 HCM in Athletes â 2024 Updates
- LIVE-HCM (2023): moderate exercise safe
- ICD â automatic disqualification
- Multidisciplinary decision-making
294.2.1.7 COVID-19 + Athletes
- 3-7 days rest if mild
- Cardiac symptoms or moderate-severe â CMR
- Myocarditis confirmed: 3-6 month exercise restriction
- Lake Louise CMR criteria
294.2.2 ææ··æ·æ¯èŒ
| Feature | Physiologic (Athletic Heart) | HCM |
|---|---|---|
| LV wall thickness | < 13 mm usually | ⥠15 mm |
| LV cavity size | Normal-â (endurance) | Normal-â |
| Diastolic function | Normal | Abnormal |
| Family hx of HCM/SCD | No | Often yes |
| Genetic testing | Negative | Sarcomere mutation |
| Detraining response | Reverse | No |
| Symptoms | None | Often dyspnea, syncope, chest pain |